123 The results will allow to decide whether the CV protection by SGLT-2 inhibitors could be extended to all patients at risk of CVD (both in primary and secondary prevention) and whether the awaited findings with dapagliflozin support a class effect without significant heterogeneity
Relevant tests include HbA1c (blood sugar control over 3 months), fasting glucose, lipid panel (cholesterol and triglycerides), kidney function tests, liver function tests, and thyroid function
The key ingredient, glutathione, is linked to serious health risks and potentially deadly side effects
We invited a third investigator (WY) to join the discussion and resolved discrepancies by consensus (Additional file 2: Fig
Everybody and their brother is coming. While these peptides are currently not legal to produce for anything other than research purposes, that hasnt stopped a booming gray market from exploiting that loophole